This paper is in the following e-collection/theme issue:

Policy (61) Ethics, Privacy, and Legal Issues (494) Electronic/Mobile Data Capture, Internet-based Survey & Research Methodology (847) E-Health Policy and Health Systems Innovation (242)

Published on in Vol 3, No 2 (2015): April-June

Balancing the Interests of Patient Data Protection and Medication Safety Monitoring in a Public-Private Partnership

Balancing the Interests of Patient Data Protection and Medication Safety Monitoring in a Public-Private Partnership

Balancing the Interests of Patient Data Protection and Medication Safety Monitoring in a Public-Private Partnership

Authors of this article:

Nancy A Dreyer1 Author Orcid Image ;   Stella Blackburn2 Author Orcid Image ;   Valerie Hliva3 Author Orcid Image ;   Shahrul Mt-Isa4 Author Orcid Image ;   Jonathan Richardson5 Author Orcid Image ;   Anna Jamry-Dziurla6 Author Orcid Image ;   Alison Bourke7 Author Orcid Image ;   Rebecca Johnson8 Author Orcid Image
Article Authors Cited by (12) Tweetations (1) Metrics

Journals

  1. Richardson J, Stephens S, Thomas S, Jamry-Dziurla A, de Jong-van den Berg L, Zetstra - van der Woude P, Laursen M, Hliva V, Mt-Isa S, Bourke A, Dreyer N, Blackburn S. An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy. JMIR Public Health and Surveillance 2016;2(1):e13 View
  2. Fiske A, Prainsack B, Buyx A. Data Work: Meaning-Making in the Era of Data-Rich Medicine. Journal of Medical Internet Research 2019;21(7):e11672 View
  3. Urushihara H, Parmenter L, Tashiro S, Matsui K, Dreyer N. Bridge the gap: The need for harmonized regulatory and ethical standards for postmarketing observational studies. Pharmacoepidemiology and Drug Safety 2017;26(11):1299 View
  4. Pappa D, Stergioulas L. Harnessing social media data for pharmacovigilance: a review of current state of the art, challenges and future directions. International Journal of Data Science and Analytics 2019;8(2):113 View
  5. Laursen M, Hallgreen C, Dreyer N, Bourke A, Mt‐Isa S, Blackburn S. Comparison of electronic self‐reported prescription medication use during pregnancy with the national prescription register in Denmark. Pharmacoepidemiology and Drug Safety 2020;29(3):328 View
  6. Matsuda S, Aoki K, Tomizawa S, Sone M, Tanaka R, Kuriki H, Takahashi Y. Analysis of Patient Narratives in Disease Blogs on the Internet: An Exploratory Study of Social Pharmacovigilance. JMIR Public Health and Surveillance 2017;3(1):e10 View
  7. Dreyer N, Blackburn S, Mt-Isa S, Richardson J, Thomas S, Laursen M, Zetstra-van der Woude P, Jamry-Dziurla A, Hliva V, Bourke A, de Jong-van den Berg L. Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy. JMIR Public Health and Surveillance 2015;1(2):e22 View
  8. Dreyer N, Rodriguez A. The fast route to evidence development for value in healthcare. Current Medical Research and Opinion 2016;32(10):1697 View
  9. Geneviève L, Martani A, Mallet M, Wangmo T, Elger B, Wasserman D. Factors influencing harmonized health data collection, sharing and linkage in Denmark and Switzerland: A systematic review. PLOS ONE 2019;14(12):e0226015 View
  10. Tanemura N, Sasaki T, Sato J, Urushihara H. Study factors associated with the incompletion of clinical trials that include pediatric patients: a retrospective analysis of the European Clinical Trials Database and a lesson from the European region. Trials 2021;22(1) View
  11. Moore A, Blumenthal K, Chambers C, Namazy J, Nowak-Wegrzyn A, Phillips E, Rider N. Improving Clinical Practice Through Patient Registries in Allergy and Immunology. The Journal of Allergy and Clinical Immunology: In Practice 2024;12(10):2599 View

Books/Policy Documents

  1. Dreyer N, Macedo A, Velentgas P. Pharmacoepidemiology. View